When the Document Coughs: FDA’s Warning Letter to CareFusion 213, LLC
The FDA’s Warning Letter to CareFusion 213 unveils a chilling archive of recurring sterility failures at the El Paso facility, demanding a system overhaul.
CGMP Violations
End of content
End of content